Charles River Laboratories International Inc. Stock Underperforms Monday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.Charles River Laboratories International Inc. (CRL) shares fell 1.57% to $229.75 on Monday, underperforming the broader market and its peers during a grim trading session. This marks the stock's second consecutive day of losses, leaving it 3.41% below its 52-week high. Trading volume exceeded the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Charles River Laboratories International Inc. (CRL) shed 1.57% to $229.75 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.79% to 7,515.34 and Dow Jones Industrial Average falling 0.26% to 52,498.64.
This was the stock's second consecutive day of losses.
Charles River Laboratories International Inc. closed 3.41% short of its 52-week high of $237.86, which the company reached on July 10th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Labcorp Holdings Inc. (LH) fell 0.05% to $276.68, Alnylam Pharmaceuticals Inc. (ALNY) fell 3.58% to $288.06, and Bio-Techne Corp. (TECH) rose 0.08% to $71.36.
Trading volume (910,091) eclipsed its 50-day average volume of 896,602.
Data source: Dow Jones Market Data, FactSet. Data compiled July 13, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-13-26 1716ET